These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8093562)

  • 1. A hepatitis B virus pre-S-retinoic acid receptor beta chimera transforms erythrocytic progenitor cells in vitro.
    Garcia M; de Thé H; Tiollais P; Samarut J; Dejean A
    Proc Natl Acad Sci U S A; 1993 Jan; 90(1):89-93. PubMed ID: 8093562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myb-Ets fusion oncoprotein inhibits thyroid hormone receptor/c-ErbA and retinoic acid receptor functions: a novel mechanism of action for leukemogenic transformation by E26 avian retrovirus.
    Rascle A; Ferrand N; Gandrillon O; Samarut J
    Mol Cell Biol; 1996 Nov; 16(11):6338-51. PubMed ID: 8887663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation of the v-erbA protein is required for its function as an oncogene.
    Glineur C; Zenke M; Beug H; Ghysdael J
    Genes Dev; 1990 Oct; 4(10):1663-76. PubMed ID: 1979040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-ErbA, but not v-ErbA, competes with a putative erythroid repressor for binding to the carbonic anhydrase II promoter.
    Rascle A; Ghysdael J; Samarut J
    Oncogene; 1994 Oct; 9(10):2853-67. PubMed ID: 7916146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The v-erb A oncogene causes repression of erythrocyte-specific genes and an immature, aberrant differentiation phenotype in normal erythroid progenitors.
    Schroeder C; Raynoschek C; Fuhrmann U; Damm K; Vennström B; Beug H
    Oncogene; 1990 Oct; 5(10):1445-53. PubMed ID: 1979159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. v-erbA oncogene activation entails the loss of hormone-dependent regulator activity of c-erbA.
    Zenke M; Muñoz A; Sap J; Vennström B; Beug H
    Cell; 1990 Jun; 61(6):1035-49. PubMed ID: 1972036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The v-erbA oncogene requires cooperation with tyrosine kinases to arrest erythroid differentiation induced by ligand-activated endogenous c-erbA and retinoic acid receptor.
    Schroeder C; Gibson L; Beug H
    Oncogene; 1992 Feb; 7(2):203-16. PubMed ID: 1347913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of normal erythroid differentiation by the endogenous thyroid hormone and retinoic acid receptors: a possible target for v-erbA oncogene action.
    Schroeder C; Gibson L; Zenke M; Beug H
    Oncogene; 1992 Feb; 7(2):217-27. PubMed ID: 1347914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. v-erbA acts on retinoic acid receptors in immature avian erythroid cells.
    Sande S; Sharif M; Chen H; Privalsky M
    J Virol; 1993 Feb; 67(2):1067-74. PubMed ID: 8093487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The nuclear oncogenes v-erbA and v-ets cooperate in the induction of avian erythroleukemia.
    Metz T; Graf T
    Oncogene; 1992 Mar; 7(3):597-605. PubMed ID: 1347919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. v-jun cooperates with v-erbB to transform the thrombocytic/megakaryocytic lineage.
    Garcia M; Samarut J
    Proc Natl Acad Sci U S A; 1993 Oct; 90(19):8837-41. PubMed ID: 8105467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unliganded T3R, but not its oncogenic variant, v-erbA, suppresses RAR-dependent transactivation by titrating out RXR.
    Barettino D; Bugge TH; Bartunek P; Vivanco Ruiz MD; Sonntag-Buck V; Beug H; Zenke M; Stunnenberg HG
    EMBO J; 1993 Apr; 12(4):1343-54. PubMed ID: 8096810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mutated, myeloid cell-specific growth factor receptor v-fms transforms avian erythroid but not myeloid cells.
    Fuhrmann U; Vennström B; Beug H
    Genes Dev; 1989 Dec; 3(12B):2072-82. PubMed ID: 2560752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A truncated RAR alpha co-operates with the v-erbB oncogene to transform early haematopoietic progenitors in vitro and in vivo.
    Altabef M; Garcia M; Varior-Krishnan G; Samarut J
    Oncogene; 1997 Mar; 14(12):1471-9. PubMed ID: 9136991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of v-rel in a replication competent virus: transformation and biochemical characterization.
    Morrison LE; Boehmelt G; Beug H; Enrietto PJ
    Oncogene; 1991 Sep; 6(9):1657-66. PubMed ID: 1656369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Requirement for the C-terminal domain of the v-erbA oncogene protein for biological function and transcriptional repression.
    Forrest D; Muñoz A; Raynoschek C; Vennström B; Beug H
    Oncogene; 1990 Mar; 5(3):309-16. PubMed ID: 1969136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-erbA alpha/T3R and RARs control commitment of hematopoietic self-renewing progenitor cells to apoptosis or differentiation and are antagonized by the v-erbA oncogene.
    Gandrillon O; Ferrand N; Michaille JJ; Roze L; Zile MH; Samarut J
    Oncogene; 1994 Mar; 9(3):749-58. PubMed ID: 7906409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional inhibition of retinoic acid response by dominant negative retinoic acid receptor mutants.
    Damm K; Heyman RA; Umesono K; Evans RM
    Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2989-93. PubMed ID: 8096643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid hormone receptor/and v-erbA. A single amino acid difference in the C-terminal region influences dominant negative activity and receptor dimer formation.
    Selmi S; Samuels HH
    J Biol Chem; 1991 Jun; 266(18):11589-93. PubMed ID: 1675637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The carbonic anhydrase II gene, a gene regulated by thyroid hormone and erythropoietin, is repressed by the v-erbA oncogene in erythrocytic cells.
    Pain B; Melet F; Jurdic P; Samarut J
    New Biol; 1990 Mar; 2(3):284-94. PubMed ID: 2126201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.